Brief: Bora Pharmaceuticals Buys Upsher-Smith Laboratories For $210 Mln
16/01/2024 09:34
Jan 16 (Reuters) - Bora Pharmaceuticals 6472.TW :
* SAYS IT BUYS 100% OF UPSHER-SMITH LABORATORIES FROM SAWAI
GROUP
4887.T , SUMITOMO CORPORATION OF AMERICAS FOR $210 MILLION
Source text for Eikon: ID:nMOP4PTPSg
Further company coverage: 6472.TW
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on BORA PHARMACEUTICALS
See all newsAI shortens drug discovery to around 1 year in China, Insilico CEO says
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
Brief: Bora Pharmaceuticals & GSK Sign $250M Five Year Global Manufacturing Contract
Brief: Bora Pharmaceuticals Says Jan-Sept Net Profit T$2.65 Bln